Chromogranin A ELISA kit ELISA
Follow guidelines and use as a tool for diagnosis, evaluation of treatment efficiency and prognostic factor for NETs
Diagnose and follow-up in pheochromocytoma, gastrinoma, carcinoid tumors
Use as adverse prognostic factor in prostate cancer
- THE ONLY PATENTED ASSAY TARGETING THE CORE OF THE MOLECULE (145-245)
- AUTOMATION FRIENDLY
Two monoclonal antibodies directed against the unprocessed central domain are used for the sandwich. A first monoclonal antibody is immobilized on the microplate, while a second monoclonal antibody is conjugated to Horse-Radish-Peroxidase.
Two alternative procedures:
1- long protocol: 16-20h at RT + 2h at RT / shaking + 10 min at RT / shaking)
2- short protocol: 2h at RT / shaking + 2h at RT / shaking + 10 min at RT / shaking.
Working range: 7 – 870 ng/mL
Sample: serum or plasma – 20 µL
Analytical sensitivity: 7 ng/mL
Functional sensitivity: 11 ng/mL
|Sérum||114||44||27 - 94|
|Plasma||114||52||20 - 104|